nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in Taiwan
|
Huang, Li-Min |
|
2014 |
32 |
41 |
p. 5363-5369 7 p. |
artikel |
2 |
Development of serum antibodies during early infancy in rhesus macaques: Implications for humoral immune responses to vaccination at birth
|
Shen, Chanjuan |
|
2014 |
32 |
41 |
p. 5337-5342 6 p. |
artikel |
3 |
Editorial Board/Aims and Scope
|
|
|
2014 |
32 |
41 |
p. IFC- 1 p. |
artikel |
4 |
Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen
|
Oreshkova, N. |
|
2014 |
32 |
41 |
p. 5323-5329 7 p. |
artikel |
5 |
Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: Lessons for vaccine introduction
|
Wallace, Aaron S. |
|
2014 |
32 |
41 |
p. 5301-5310 10 p. |
artikel |
6 |
Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine
|
Duan, Zhaojun |
|
2014 |
32 |
41 |
p. 5316-5322 7 p. |
artikel |
7 |
Global vaccine supply. The increasing role of manufacturers from middle income countries
|
Francis, Donald P. |
|
2014 |
32 |
41 |
p. 5259-5265 7 p. |
artikel |
8 |
Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
|
Uraki, Ryuta |
|
2014 |
32 |
41 |
p. 5295-5300 6 p. |
artikel |
9 |
Influenza vaccine effectiveness against medically-attended influenza illness during the 2012–2013 season in Beijing, China
|
Yang, Peng |
|
2014 |
32 |
41 |
p. 5285-5289 5 p. |
artikel |
10 |
Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case–control study
|
Spadea, A. |
|
2014 |
32 |
41 |
p. 5290-5294 5 p. |
artikel |
11 |
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes
|
Barzon, Luisa |
|
2014 |
32 |
41 |
p. 5357-5362 6 p. |
artikel |
12 |
No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration
|
Tekleghiorghis, Tesfaalem |
|
2014 |
32 |
41 |
p. 5330-5336 7 p. |
artikel |
13 |
Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial
|
Dotres, Carlos P. |
|
2014 |
32 |
41 |
p. 5266-5270 5 p. |
artikel |
14 |
Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia
|
Jõgi, Piia |
|
2014 |
32 |
41 |
p. 5311-5315 5 p. |
artikel |
15 |
The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009–2013
|
Cowling, Benjamin J. |
|
2014 |
32 |
41 |
p. 5278-5284 7 p. |
artikel |
16 |
Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism
|
Lv, Xiaobo |
|
2014 |
32 |
41 |
p. 5343-5352 10 p. |
artikel |
17 |
The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck tembusu virus
|
Chen, Pucheng |
|
2014 |
32 |
41 |
p. 5271-5277 7 p. |
artikel |
18 |
Varicella hospitalizations in Los Angeles during the varicella vaccination era, 2003–2011: Are they preventable?
|
Agopian, Anya |
|
2014 |
32 |
41 |
p. 5353-5356 4 p. |
artikel |